Literature DB >> 26219391

Flavonoids, Breast Cancer Chemopreventive and/or Chemotherapeutic Agents

Chantal Beatrice Magne Nde1, Stephane Zingue, Evelyn Winter, Tania Beatriz Creczynski-Pasa, Thomas Michel, Xavier Fernandez, Dieudonne Njamen, Colin Clyne.   

Abstract

Flavonoids are secondary metabolites abundantly present in commonly consumed fruits and vegetables. They possess diverse properties such as anti-inflammatory, anti-oxidant and anti-cancer. Epidemiologic studies suggest that an enrich flavonoids diet is linked to a decreased risk of breast cancer. These protective properties are due to the alteration of numerous signalling pathways involved in cancer-related phenomena such as inflammation and proliferation. Human clinical trials examining the effect of supplementation of some flavonoids on disease prevention have been conducted. There is no natural flavonoid that has been approved for the treatment of breast cancer. However, natural flavonoids served as lead compounds in the synthesis of cancer chemopreventive and/or therapeutic agents.

Entities:  

Year:  2015        PMID: 26219391

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  4 in total

1.  Inhibitory Effects of Tangeretin, A Citrus Peel-Derived Flavonoid, on Breast Cancer Stem Cell Formation through Suppression of Stat3 Signaling.

Authors:  Yu-Chan Ko; Hack Sun Choi; Ren Liu; Ji-Hyang Kim; Su-Lim Kim; Bong-Sik Yun; Dong-Sun Lee
Journal:  Molecules       Date:  2020-06-03       Impact factor: 4.411

2.  Study of Microbiomes in Aseptically Collected Samples of Human Breast Tissue Using Needle Biopsy and the Potential Role of in situ Tissue Microbiomes for Promoting Malignancy.

Authors:  Shen Meng; Bin Chen; Junjie Yang; Jingwen Wang; Dequan Zhu; Qingsong Meng; Lei Zhang
Journal:  Front Oncol       Date:  2018-08-17       Impact factor: 6.244

3.  Potential Therapeutic Anti-Inflammatory and Immunomodulatory Effects of Dihydroflavones, Flavones, and Flavonols.

Authors:  Cristina Zaragozá; Lucinda Villaescusa; Jorge Monserrat; Francisco Zaragozá; Melchor Álvarez-Mon
Journal:  Molecules       Date:  2020-02-24       Impact factor: 4.411

4.  Delphinidin-3-glucoside suppresses breast carcinogenesis by inactivating the Akt/HOTAIR signaling pathway.

Authors:  Xiaohong Yang; En Luo; Xin Liu; Bin Han; Xiaoping Yu; Xiaoli Peng
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.